Saturday, March 29, 2014 2:37:21 PM
A 1% penetration of just the US Market for RED SUN and MAGIC (all international sales ignored) would be roughly equivalent to $1B in market capitalization for XXII (share price of roughly $18-19). Similar metrics (x% = $xB MC) have been used to valuate Lorillard (LO), who only sells products in the US. Last I checked LO captured about 14% market share.
For every 99 packs of competitor's product sold in the US, XXII would need to sell just one pack of their super-premium brands to maintain that 1%.
Of course, the super-premium cigarette sales are just one of 5 (many more if you count wild cards possible with their patented plant biotechnology and ability to manipulate genes: MJ, biofuel, tobacco-based vaccines, etc.) potential revenue streams publicly stated by the Company that can contribute to 22nd Century's valuation going forward.
JustfactsMam has provided those details of the other Company-disclosed revenue streams in a previous post, so I will not be redundant.
For every 99 packs of competitor's product sold in the US, XXII would need to sell just one pack of their super-premium brands to maintain that 1%.
Of course, the super-premium cigarette sales are just one of 5 (many more if you count wild cards possible with their patented plant biotechnology and ability to manipulate genes: MJ, biofuel, tobacco-based vaccines, etc.) potential revenue streams publicly stated by the Company that can contribute to 22nd Century's valuation going forward.
JustfactsMam has provided those details of the other Company-disclosed revenue streams in a previous post, so I will not be redundant.
DD is King. Know What You Own.
Recent XXII News
- 22nd Century Group Shares 2026 Vision for VLN® Product Growth and Tobacco Harm Reduction Leadership • GlobeNewswire Inc. • 04/29/2026 08:35:00 PM
- 22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University • GlobeNewswire Inc. • 04/23/2026 11:50:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/13/2026 04:15:24 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/10/2026 08:35:13 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/10/2026 08:30:36 PM
- 22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product Initiative • GlobeNewswire Inc. • 04/07/2026 12:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/31/2026 09:00:54 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/27/2026 08:30:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 12:02:51 PM
- 22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/26/2026 10:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/24/2026 05:57:09 PM
- 22nd Century Group to Announce Fourth Quarter and Full Year 2025 Results on March 26, 2026 • GlobeNewswire Inc. • 03/23/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 09:14:20 PM
- 22nd Century Group Reports Continued Early Sales Momentum for VLN® Cigarette Products • GlobeNewswire Inc. • 02/23/2026 10:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 09:15:28 PM
- 22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/20/2026 09:15:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/17/2026 04:59:02 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/13/2026 07:17:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 01:00:48 PM
- 22nd Century CEO & Chairman Larry Firestone Provides 2025 Year-in-Review Letter to Stockholders • GlobeNewswire Inc. • 01/15/2026 02:00:00 PM
- 22nd Century to Participate in the Needham Annual Growth Conference January 16, 2026 • GlobeNewswire Inc. • 01/12/2026 09:30:00 PM
- 22nd Century Files VLN® MRTP Renewal – Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less • GlobeNewswire Inc. • 01/06/2026 11:10:00 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/30/2025 10:19:44 PM
